Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

Related Articles by Review for PubMed (Select 12926839)

1.

Effects of glatiramer acetate on relapse rate and accumulated disability in multiple sclerosis: meta-analysis of three double-blind, randomized, placebo-controlled clinical trials.

Martinelli Boneschi F, Rovaris M, Johnson KP, Miller A, Wolinsky JS, Ladkani D, Shifroni G, Comi G, Filippi M.

Mult Scler. 2003 Aug;9(4):349-55.

PMID:
12926839
2.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
3.

Spotlight on glatiramer acetate in relapsing-remitting multiple sclerosis.

Simpson D, Noble S, Perry C.

BioDrugs. 2003;17(3):207-10. Review.

PMID:
12749757
4.

Management of worsening multiple sclerosis with mitoxantrone: a review.

Fox EJ.

Clin Ther. 2006 Apr;28(4):461-74. Review.

PMID:
16750460
5.

Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.

Filippini G, Del Giovane C, Vacchi L, D'Amico R, Di Pietrantonj C, Beecher D, Salanti G.

Cochrane Database Syst Rev. 2013 Jun 6;6:CD008933. doi: 10.1002/14651858.CD008933.pub2. Review.

PMID:
23744561
6.

Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.

Carter NJ, Keating GM.

Drugs. 2010 Aug 20;70(12):1545-77. doi: 10.2165/11204560-000000000-00000. Review.

PMID:
20687620
7.

Glatiramer acetate therapy for multiple sclerosis: a review.

Perumal J, Filippi M, Ford C, Johnson K, Lisak R, Metz L, Tselis A, Tullman M, Khan O.

Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):1019-29. Review.

PMID:
17125414
8.

Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis.

Simpson D, Noble S, Perry C.

CNS Drugs. 2002;16(12):825-50. Review.

PMID:
12421116
9.

Therapy with glatiramer acetate for multiple sclerosis.

Munari L, Lovati R, Boiko A.

Cochrane Database Syst Rev. 2004;(1):CD004678. Review. Update in: Cochrane Database Syst Rev. 2010;(5):CD004678.

PMID:
14974077
10.

Benefit-risk analysis of glatiramer acetate for relapsing-remitting and clinically isolated syndrome multiple sclerosis.

Qizilbash N, Mendez I, Sanchez-de la Rosa R.

Clin Ther. 2012 Jan;34(1):159-176.e5. doi: 10.1016/j.clinthera.2011.12.006. Review.

PMID:
22284996
11.
12.

Glatiramer acetate for multiple sclerosis.

La Mantia L, Munari LM, Lovati R.

Cochrane Database Syst Rev. 2010 May 12;(5):CD004678. doi: 10.1002/14651858.CD004678.pub2. Review.

PMID:
20464733
13.

Glatiramer acetate.

Comi G, Moiola L.

Neurologia. 2002 May;17(5):244-58. Review.

PMID:
12031214
14.

Lessons from randomised direct comparative trials.

Achiron A, Fredrikson S.

J Neurol Sci. 2009 Feb 1;277 Suppl 1:S19-24. doi: 10.1016/S0022-510X(09)70007-3. Review.

PMID:
19200860
15.

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Miller RG, Mitchell JD, Lyon M, Moore DH.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep;4(3):191-206. Review.

PMID:
13129806
16.
17.

Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.

Clerico M, Faggiano F, Palace J, Rice G, Tintorè M, Durelli L.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005278. doi: 10.1002/14651858.CD005278.pub3. Review.

PMID:
18425915
18.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

19.

Glatiramer acetate for multiple sclerosis.

[No authors listed]

Drug Ther Bull. 2001 Jun;39(6):41-3. Review.

PMID:
11432030
20.

Considerations in the treatment of relapsing-remitting multiple sclerosis.

Calabresi PA.

Neurology. 2002 Apr 23;58(8 Suppl 4):S10-22. Review.

PMID:
11971122
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk